Urgent.News

What's breaking now, across thousands of outlets.

AI

AI drug discovery giant Isomorphic Labs raises €4.5 billion in blockbuster funding round

Isomorphic Labs, an AI company focussed on designing and developing new medicines, today announced a €4.5 billion ($5 billion) Series C financing round to accelerate the scientific breakthroughs and proprietary AI advances. The round was co-led by Greenoaks and Sequoia Capital, alongside Andreessen Horowitz, with continued significant investment from Alphabet. The round also included…

Isomorphic Labs, an AI-driven biopharmaceutical company, has announced a €4.5 billion ($5 billion) Series C funding round to accelerate its innovative drug discovery processes and AI advancements. Co-led by Greenoaks and Sequoia Capital, with participation from Andreessen Horowitz, Alphabet, and existing investors Thrive Capital, MGX, GV, CapitalG, Temasek, and the UK Sovereign AI Fund, the round signifies a significant boost for the company.

Isomorphic Labs' AI drug design engine, IsoDDE, generates molecules with unprecedented precision and speed, allowing the company to develop foundational biology models and deepen its understanding of systemic diseases. The funding will further advance IsoDDE, expand into new biology, and build global infrastructure to power AI-led bioengineering.

Written by urgent.news from EU-Startups's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at eu-startups.com →

More in AI

Build-Time AI: How We Validate 5,000 Prices Across 8 Languages Without a Server

The problem We run a transport booking site in Morocco — navetteforyou.com . Eight languages, 641 pages, thousands of prices.

  • Navetteforyou.com validates 5,000 prices in 8 languages without server
  • AI-assisted build-time pipeline checks prices, minimums, consistency
  • Zero pricing errors in production since deployment, 4-second build time

More from Tuesday 17 November →